Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)

AIM: The aim is to report the long‐term outcomes of preoperative cisplatin and fluorouracil plus docetaxel (DCF) vs Adriamycin (ACF) for resectable esophageal squamous cell carcinoma (ESCC). Previously, this trial showed that DCF is associated with prolonged recurrence‐free survival (RFS). METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Gastroenterol Surg
Hlavní autoři: Sugimura, Keijiro, Yamasaki, Makoto, Yasuda, Takushi, Yano, Masahiko, Hirao, Motohiro, Fujitani, Kazumasa, Kimura, Yutaka, Miyata, Hiroshi, Motoori, Masaaki, Takeno, Atsushi, Shiraishi, Osamu, Makino, Tomoki, Kii, Takayuki, Tanaka, Koji, Satoh, Taro, Mori, Masaki, Doki, Yuichiro
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7832970/
https://ncbi.nlm.nih.gov/pubmed/33532683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12388
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky